{"transactions":[{"id":1517181,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:33:30.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":10108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 10, 2034 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":10108,"derivative":{"exercise_price":5.75,"exercise_date":"2025-05-10","underlying":"Common Stock","underlying_shares":10108},"source":{"system":"sec-edgar","filing":"0001062993-24-010183","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324010183/form4.xml","form_type":"4"}},{"id":1517180,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T16:33:30.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":543,"price":5.75,"value":3122.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these restricted shares in lieu of $3,125 for retainer and meeting fees during the first quarter of 2024."}],"balance_after":543,"source":{"system":"sec-edgar","filing":"0001062993-24-010183","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324010183/form4.xml","form_type":"4"}},{"id":1698477,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-28T16:31:17.000Z","date":"2023-12-26","kind":"sale","planned":false,"acquired":false,"shares":3149,"price":0.72,"value":2267.28,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-23-023239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323023239/form4.xml","form_type":"4"}},{"id":1713870,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-12T16:31:18.000Z","date":"2023-12-08","kind":"sale","planned":false,"acquired":false,"shares":1334,"price":0.67,"value":893.78,"ownership":{"direct":true},"balance_after":3149,"source":{"system":"sec-edgar","filing":"0001062993-23-022436","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323022436/form4.xml","form_type":"4"}},{"id":1893253,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-15T16:31:05.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":143848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":143848,"derivative":{"exercise_price":0.41,"exercise_date":"2024-05-11","underlying":"Common Stock","underlying_shares":143848},"source":{"system":"sec-edgar","filing":"0001062993-23-011108","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323011108/form4.xml","form_type":"4"}},{"id":2103246,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-28T16:33:02.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":47232,"price":0.5293,"value":24999.8976,"ownership":{"direct":true},"balance_after":67232,"source":{"system":"sec-edgar","filing":"0001062993-22-022813","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322022813/form4.xml","form_type":"4"}},{"id":2271725,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-13T16:43:53.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":53254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":53254,"derivative":{"exercise_price":1.12,"exercise_date":"2023-05-12","underlying":"Common Stock","underlying_shares":53254},"source":{"system":"sec-edgar","filing":"0001062993-22-012388","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322012388/form4.xml","form_type":"4"}},{"id":2374342,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-24T16:37:01.000Z","date":"2022-02-23","kind":"purchase","acquired":true,"shares":18000,"price":1.32,"value":23760.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001062993-22-005567","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322005567/form4.xml","form_type":"4"}},{"id":2374341,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-24T16:37:01.000Z","date":"2022-02-23","kind":"purchase","acquired":true,"shares":2000,"price":1.3,"value":2600.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001062993-22-005567","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322005567/form4.xml","form_type":"4"}},{"id":2716051,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-12T16:23:51.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":28586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":28586,"derivative":{"exercise_price":2.15,"exercise_date":"2022-05-11","underlying":"Common Stock","underlying_shares":28586},"source":{"system":"sec-edgar","filing":"0000891839-21-000136","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183921000136/edgar.xml","form_type":"4"}},{"id":3145149,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-18T16:20:29.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":15679,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":15679,"derivative":{"exercise_price":3.95,"exercise_date":"2021-05-14","underlying":"Common Stock","underlying_shares":15679},"source":{"system":"sec-edgar","filing":"0000891839-20-000119","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000119/edgar.xml","form_type":"4"}},{"id":3310650,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-15T16:20:55.000Z","date":"2019-06-30","kind":"grant","acquired":true,"shares":2385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":2385,"derivative":{"exercise_price":5.52,"exercise_date":"2019-06-30","expiration_date":"2029-06-29","underlying":"Common Stock","underlying_shares":2385},"source":{"system":"sec-edgar","filing":"0000891839-20-000030","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000030/edgar.xml","form_type":"4"}},{"id":3317932,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-06T16:34:42.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":2737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the fourth quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":2737,"derivative":{"exercise_price":4.85,"exercise_date":"2019-12-31","expiration_date":"2029-12-28","underlying":"Common Stock","underlying_shares":2737},"source":{"system":"sec-edgar","filing":"0000891839-20-000018","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000018/edgar.xml","form_type":"4"}},{"id":3317870,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-06T16:32:01.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":1856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The original Form 4 contained an incorrect expiration date for these options. This amendment is being filed to correct the expiration date."}],"balance_after":1856,"derivative":{"exercise_price":7.17,"exercise_date":"2019-09-30","expiration_date":"2029-09-27","underlying":"Common Stock","underlying_shares":1856},"source":{"system":"sec-edgar","filing":"0000891839-20-000016","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000016/edgar.xml","form_type":"4/A","original_submission_date":"2019-10-04"}},{"id":3397213,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-04T10:57:51.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":1856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exercisable."}],"balance_after":1856,"derivative":{"exercise_price":7.17,"exercise_date":"2019-09-30","expiration_date":"2019-09-27","underlying":"Common Stock","underlying_shares":1856},"source":{"system":"sec-edgar","filing":"0001209191-19-052506","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000120919119052506/doc4.xml","form_type":"4"}},{"id":3520375,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-17T16:41:45.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":7718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":7718,"derivative":{"exercise_price":7.78,"exercise_date":"2020-05-15","underlying":"Common Stock","underlying_shares":7718},"source":{"system":"sec-edgar","filing":"0000891839-19-000070","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183919000070/edgar.xml","form_type":"4"}},{"id":3567983,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91070,"kind":"person","name":"Van Strydonck, Gerald E.","position":1,"cik":"0001748247","reported_name":"Van Strydonck, Gerald E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-02T16:31:38.000Z","date":"2019-03-31","kind":"grant","acquired":true,"shares":2501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable."}],"balance_after":2501,"derivative":{"exercise_price":5.26,"expiration_date":"2029-03-30","underlying":"Common Stock","underlying_shares":2501},"source":{"system":"sec-edgar","filing":"0000891839-19-000058","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183919000058/edgar.xml","form_type":"4"}}]}